I-123 imaging for the prediction of I-131 therapy for recurrent differentiated thyroid cancer, RDTC, when I-131 tracer is negative but raised thyroglobulin, Tg

類似資料

• The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.
  著者:: Ali, N, 等
  出版事項: (2006)
• The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning.
  著者:: Siddiqi, A, 等
  出版事項: (2001)
• Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
  著者:: Mukherjee, J, 等
  出版事項: (2001)
• Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
  著者:: Kaltsas, G, 等
  出版事項: (2003)
• NMR-ON MEASUREMENTS OF I-123, I-124, I-131 IN NICKEL
  著者:: Ohya, S, 等
  出版事項: (1992)